Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

60.86
BATS BZX Real-Time Price
As of 11:49am ET
 -0.34 / -0.56%
Today’s Change
45.45
Today|||52-Week Range
71.60
+2.73%
Year-to-Date
M&A: back with a bang
10:09am / FT.com
AbbVie (ABBV) Likely to Beat on Q1 Earnings: Stock to Gain?
Apr 22 / Zacks.com
Capture A Potential 35% Gain With This Fast-Growing Stock
Apr 28 / StreetAuthority
Roche (RHHBY) Beats on Q1 Sales, New Launches in Focus (revised)
Apr 21 / Zacks.com
Cramer: Worst May Be Over for Embattled Pharma
Apr 28 / TheStreet.com
The Zacks Analyst Blog Highlights: Medivation, Synta, AbbVie, Gilead and Orexigen
Apr 21 / Zacks.com
Three pharma deals worth $45bn reignite M&A boom
Apr 28 / FT.com
Value, Yield a Must in 'Wade Boggs' Market
Apr 21 / TheStreet.com
$40 Billion Takeover Has Big Pharma Giddy
Apr 28 / TheStreet.com
Better Buy: Pfizer Inc. vs. AbbVie
Apr 21 / MotleyFool.com
AbbVie joins wave of pharma moves with Stemcentrx deal
Apr 28 / FT.com
Biotech Stock Roundup: Medivation Buyout Rumors Resurface, Synta Up on Merger Deal
Apr 20 / Zacks.com
The Zacks Analyst Blog Highlights: Biogen, Sarepta, Catalyst Pharmaceuticals, AbbVie ...
Apr 28 / Zacks.com
Healthcare ETFs to Buy on Blockbuster J&J Q1 Results
Apr 20 / Zacks.com
Will Poor Earnings Bring Down the Market?
Apr 28 / TheStreet.com
9 Health Names to Like Amid the Rhetoric
Apr 20 / TheStreet.com
AbbVie (ABBV) Beats on 1Q Earnings, Lowers View on Deal
Apr 28 / Zacks.com
What Earnings Season Shows So Far
Apr 19 / TheStreet.com
AbbVie (ABBV) Tops 1Q Earnings Estimates, Announces Deal
Apr 28 / Zacks.com
UK companies more likely to hire outside CEOs
Apr 18 / FT.com
AbbVie (ABBV) Stock Tumbles, Revises 2016 Outlook to Reflect Stemcentrx Acquisition
Apr 28 / TheStreet.com
4 Healthcare Stocks That Are Looking Cheap
Apr 17 / MotleyFool.com
AbbVie (ABBV) Lagging In Pre-Market Activity
Apr 28 / TheStreet.com
UnitedHealth (UNH) May Beat Q1 Earnings: Will Stock Gain?
Apr 15 / Zacks.com
Biotech Stock Roundup: Biogen Tops on Q1 Earnings, Sarepta, Catalyst Plunge on Regula...
Apr 27 / Zacks.com
Will J&J (JNJ) Pull a Surprise Again in Q1 Earnings?
Apr 15 / Zacks.com
Biotech Stock Gilead (GILD) Likely to Beat in Q1 Earnings
Apr 26 / Zacks.com
AbbVie Reveals Positive Data on Combination HCV Therapy
Apr 14 / Zacks.com
Worried About Social Security? Buy These 4 Stocks
Apr 26 / MotleyFool.com
The Zacks Analyst Blog Highlights: Intercept, Clovis, AbbVie, Relypsa and Horizon Pha...
Apr 14 / Zacks.com
5 Biotech Stocks to Bet on This Earnings Season
Apr 25 / Zacks.com
AbbVie's Venclexta Notches FDA Win, But Investors Might Want To Temper Enthusiasm
Apr 13 / MotleyFool.com
Healthcare: Britain, the test tube of the world
Apr 25 / FT.com
Biotech Stock Roundup: FDA Advisory Panels Say Yes to Intercept, No to Clovis
Apr 13 / Zacks.com
This Big Pharma Stock Is Set to Profit From an Immunology Bonanza
Apr 25 / TheStreet.com
Roche/AbbVie's Lymphocytic Leukemia Drug Gets FDA Nod
Apr 12 / Zacks.com
Centene (CNC) Q1 Earnings: Surprise in Store for Stock?
Apr 25 / Zacks.com
M&A deals worth $370bn torpedoed by Obama administration
Apr 07 / FT.com
Aetna (AET) Q1 Earnings: Is a Surprise in Store for Stock?
Apr 25 / Zacks.com
US Treasury shatters Pfizer chief Ian Read's merger dreams
Apr 06 / FT.com
Big Drug Stocks to Report This Week: LLY, GSK, VRTX, BMY, ABBV
Apr 25 / Zacks.com
Big pharma seeks digital solution to productivity problem
Apr 06 / FT.com
Goldman Sach's 5 Large-Cap Pharma Stock Favorites Ahead of Earnings
Apr 25 / TheStreet.com
Drugmakers race to prescribe preventive migraine remedies
Apr 03 / FT.com
3 Things to Watch in Gilead Sciences, Inc.'s First-Quarter Results
Apr 23 / MotleyFool.com